Advertisement

Related Videos

Opening Session Panel Discussion

Welcome and Introduction to Vi3C

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Advertisement

Advertisement




May
19
Today In Oncology
Gabapentin May Extend Survival in Patients With Glioblastoma
Stromal Disruption Associated With Higher Risk of Developing Aggressive Breast Cancer
Former President Biden Diagnosed With Metastatic Prostate Cancer
Reduced-Dose Chemoradiotherapy for Early-Stage Anal Cancer
Chemotherapy-Free Neoadjuvant Therapy for HER2-Enriched Early Breast Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo